A clinical trial listing for mazdutide was registered on November 9, 2026. The study is titled "Efficacy, Safety and Cardiovascular Protection of Mazdutide in Type 1 Diabetes." Its phase is listed as not applicable in the registry entry. The trial status is currently recorded as not yet recruiting. This means participant enrollment has not yet begun as of the listing date. The registry entry identifies the study by the identifier NCT07924553. No results, efficacy data, or safety findings have been posted for this trial at this stage. Mazdutide remains classified as an unapproved compound under research investigation. As the trial has not started recruitment, no information is available yet regarding participant outcomes or study progress. Further updates would be expected as the trial moves through recruitment and subsequent phases. Readers interested in background on mazdutide can consult the compound overview for additional context.
Mazdutide Trial in Type 1 Diabetes Registered, Not Yet Recruiting
See the full mazdutide overview
Source: https://clinicaltrials.gov/study/NCT07924553